Using advanced technologies to analyze and improve treatment for rare and pediatric cancers
Integrative Multiomics and Clinical Laboratory Translation for Advanced, Rare, and Pediatric Cancers
This study is exploring new ways to understand and treat rare and advanced cancers in kids by using the latest technology to look closely at their genes, helping doctors make better decisions for their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10977429 on NIH RePORTER |
What this research studies
This research focuses on utilizing cutting-edge technologies in genomics, transcriptomics, epigenomics, and proteomics to analyze advanced, rare, and pediatric cancers. By developing reportable test results in a clinical lab, the project aims to translate complex genetic information into actionable insights for patient care. The Mi-OncoSeq lab will employ innovative sequencing methods and bioinformatics to enhance the understanding of cancer mechanisms and improve diagnostic and therapeutic decision-making for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with advanced, rare, or pediatric cancers who may benefit from advanced genomic testing.
Not a fit: Patients with common cancers that are well understood and have established treatment protocols may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective treatment options for patients with advanced, rare, and pediatric cancers.
How similar studies have performed: Previous research has shown promise in using multiomics approaches for cancer analysis, indicating potential for success in this innovative project.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Robinson, Dan Russel — University of Michigan at Ann Arbor
- Study coordinator: Robinson, Dan Russel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.